Adaptive Biotechnologies Corp (NASDAQ: ADPT) kicked off on Tuesday, down -3.79% from the previous trading day, before settling in for the closing price of $17.41. Over the past 52 weeks, ADPT has traded in a range of $5.91-$20.76.
A company in the Healthcare sector has dropped its sales by -1.51% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 54.78%. With a float of $146.78 million, this company’s outstanding shares have now reached $152.58 million.
In an organization with 619 employees, it is important to assess its efficiency.
Adaptive Biotechnologies Corp (ADPT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 3.86%, while institutional ownership is 93.87%. The most recent insider transaction that took place on Dec 15 ’25, was worth 1,773,267. In this transaction Chief People Officer of this company sold 113,890 shares at a rate of $15.57, taking the stock ownership to the 315,978 shares. Before that another transaction happened on Dec 15 ’25, when Company’s Officer proposed sale 136,706 for $15.44, making the entire transaction worth $2,110,741.
Adaptive Biotechnologies Corp (ADPT) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.23 earnings per share (EPS), higher than consensus estimate (set at -0.24) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.59% during the next five years compared to -1.51% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Take a look at Adaptive Biotechnologies Corp’s (ADPT) current performance indicators. Last quarter, stock had a quick ratio of 3.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Let’s dig in a bit further. During the last 5-days, its volume was 2.44 million. That was better than the volume of 2.1 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 86.79%.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 62.06%, which indicates a significant decrease from 72.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.87 in the past 14 days, which was higher than the 0.84 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.56, while its 200-day Moving Average is $12.11. However, in the short run, Adaptive Biotechnologies Corp’s stock first resistance to watch stands at $17.23. Second resistance stands at $17.70. The third major resistance level sits at $17.99. If the price goes on to break the first support level at $16.47, it is likely to go to the next support level at $16.18. The third support level lies at $15.71 if the price breaches the second support level.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats
The company with the Market Capitalisation of 2.56 billion has total of 152,665K Shares Outstanding. Its annual sales at the moment are 178,960 K in contrast with the sum of -159,490 K annual income. Company’s last quarter sales were recorded 93,970 K and last quarter income was 9,550 K.
